Clinical Trials Directory

Trials / Completed

CompletedNCT02716337

Target Versus Standard Human Milk Fortification in Very Low Birth Weight Preterm Infants

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The prevention of postnatal growth failure in very low birth weight (VLBW) preterm infants is of utmost importance. Standard fortification is the most commonly used supplementation practice but it does not consider the native variability of human milk. Data on efficacy and safety of prolonged target fortification are scarce. The investigators performed a prospective interventional study in VLBW preterm infants, exclusively fed with human milk, to test efficacy and metabolic safety of target fortification in these preterm infants.

Detailed description

The prevention of postnatal growth failure in very low birth weight (VLBW) preterm infants is of utmost importance. Fortified human milk is the goal for preterm infants' nutrition. Standard fortification is the most commonly used and safe supplementation practice but it does not consider the native variability of human milk. Data on efficacy and safety of prolonged target fortification are scarce. Prospective interventional study was conducted in VLBW preterm infants, exclusively fed with human milk. Twenty-four hour collected pools of human milk were analyzed and targeted human milk fortification was performed during hospitalization. Weekly growth and daily growth velocity were compared with that of an historical group of VLBW preterm infants that had received standard fortified human milk. Osmolality, metabolic and gastrointestinal tolerance were monitored.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAddition of human milk fortifiers according to human milk analysis

Timeline

Start date
2014-10-01
Primary completion
2015-03-01
First posted
2016-03-23
Last updated
2016-03-23

Source: ClinicalTrials.gov record NCT02716337. Inclusion in this directory is not an endorsement.